The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving ...

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

Stryker reported Street-beating financial results and upped its sales forecast, but said tariffs will decrease previously ...

CEO Jason Hollar said Cardinal Health is "engaging" with the Trump Administration "to try to mitigate impact to patient care.

Baxter Chair and interim CEO Brent Shafer said some tariff mitigation activities are underway while others are being ...

Element Science announced today that it received FDA pre-market approval for its Jewel patch wearable cardioverter ...

Intuitive (NASDAQ: ISRG) announced today that it received FDA clearance for a new indication for its da Vinci single port (SP ...

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.

Precision Neuroscience announced that it appointed two significant leadership figures to support its brain-computer interface ...

Resmed (NYSE: RMD) announced today that it acquired VirtuOx, a leading independent diagnostic testing facility (IDTF).

BD (NYSE: BDX) shares took a hit today on second-quarter results that were mixed compared to the consensus forecast..